The Treatment Challenges and Limitation in High-Voltage Pediatric Electrical Burn at Rural Area

The Treatment Challenges and Limitation in High-Voltage Pediatric Electrical Burn at Rural Area: A Case Report

A case of high-voltage pediatric electrical burn involving a fully conscious 13-year old boy who was admitted to the emergency room after being electrocuted by high-voltage power cable, with superficial partial thickness burn over right arm, trunk, and left leg (26% of total body surface area) with cardiac abnormality e.g. tachycardia and non-specific ST depression. Treatments were based on Australian New Zealand Burns Association algorithm with several modifications, i.e. administering lower concentration of oxygen with nasal cannula instead of non-rebreathing mask and intravenous Ketorolac and Metamizole as analgesic instead of morphine due to limitation in infrastructure and knowledge. The patient underwent surgical debridement and strict observation with no signs of abnormality found during hospital stay. Wound dressing consisted of silver sulfadiazine, Sofra-tulle® and dry sterile gauze were used until epithelialization. After the wound healed, the patient resumed wearing elastic bandage and moisturizer on the wound area. The patient was observed daily through 7 days of hospitalization and followed-up for 1 year, achieving normal physiologic function of the affected area but unsatisfactory esthetic result. This case report showed that there is still a lack of burn prevention programs in the rural area, resulted in inadequate first aid application for electrical burn. There is a need for acknowledging and maximizing the implementation of available standardized guidelines e.g. Australian New Zealand Burns Association by giving homogenized training to personnel as well as providing feasible equipment, and then followed by strict monitoring for the patient. The focus of the burn program should also include burn rehabilitation, psychosocial needs and any complaints needing expert opinion in an outpatient setting in addition to adequate burn management for life saving and good wound healing.

Study Overview

• Status: Completed
• Conditions: Burn Scar; Burns; Burn Degree Second; Electrical Burn

• Study Type: Observational
• Enrollment (Actual): 1

Contacts and Locations

Study Locations

• Indonesia
  • East Nusa Tenggara
    • Kupang, East Nusa Tenggara, Indonesia
      • S.K.Lerik General Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Male

• Sampling Method: Non-Probability Sample

Study Population

Patient with acute electrical burn wound

Description

Inclusion Criteria:

• patient with acute electrical burn wound

Exclusion Criteria:

• patient does not want to participate

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Wound healing	The healing rate of burn wound	1 month

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Burn Scar	The appearance and function of the scar and the affected areas	1 year

Collaborators and Investigators

• Sponsor: S.K. Lerik General Hospital
• Investigators: Principal Investigator: Adi Basuki, MD, S.K.Lerik Public Hospital

Study record dates

Study Major Dates

• Study Start (Actual): August 7, 2017
• Primary Completion (Actual): August 10, 2018
• Study Completion (Actual): August 10, 2018

Study Registration Dates

• First Submitted: February 24, 2021
• First Submitted That Met QC Criteria: February 24, 2021
• First Posted (Actual): February 26, 2021

Study Record Updates

• Last Update Posted (Actual): March 1, 2021
• Last Update Submitted That Met QC Criteria: February 25, 2021
• Last Verified: February 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Wounds and Injuries; Electric Injuries; Burns; Burns, Electric
• Other Study ID Numbers: SKL002

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No